Robert E. Gagnon insider trades

Open-market stock purchases and sales by Robert E. Gagnon, Director at Harvard Bioscience Inc, from SEC Form 4 filings since Dec 1, 2010.

Track record: 100% of 6 scored buys are up 5% or more since purchase, averaging +128%.

Recent trades

DateStockTradeValue
Jun 9, 2026HBIO Harvard Bioscience IncBought (not open market)—
Apr 23, 2026IRD Opus Genetics, IncSold$40.7K
Jan 22, 2026IRD Opus Genetics, IncBought (not open market)—
Dec 16, 2025VSTM Verastem, IncSold$2.6K

Companies traded

  • HBIO Harvard Bioscience Inc: 6 buys, 12 sales, last Jun 9, 2026
  • IRD Opus Genetics, Inc: 1 sale, last Apr 23, 2026
  • VSTM Verastem, Inc: 30 sales, last Dec 16, 2025
  • BBLG Bone Biologics Corp: other filings, last Jun 4, 2025
  • CLH Clean Harbors Inc: other filings, last Sep 11, 2012
  • BIIB Biogen Idec Inc: 21 sales, last Feb 29, 2012

Get free alerts when Robert E. Gagnon files a new trade →